Spinnovation expands into the US

25-Jan-2012 - USA

Spinnovation announces that it further anchors its presence in the US market through the collaboration with Quantum Tessera in Collegeville, Pennsylvania. This exciting extension to the business came after the Company trebled the number of clients in the biotech and pharma markets last year. Dr Edward Zartler from Quantum Tessera, will be working with Spinnovation to develop biologic and biosimilar characterisation markets in the US.

Dr Frederic Girard, CEO of NMR services specialist Spinnovation said “The new presence in the US has enabled us to take advantage of the expanding interest in bioprocess technologies to support the manufacture of biologics. We are gaining momentum with new companies in new markets, and are very excited to see what the future holds.”

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances